Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
JAMA Dermatology
Published October 21, 2026
Evaluating the Performance of Melanoma Risk Prediction Models.
October 23, 2026
Medspoke
Medspoke
JAMA Dermatology
Published October 21, 2026
00:00
--:--
Refractory Phaeohyphomycosis Due to CARD9 Variants.
October 23, 2026
Share
Refractory Phaeohyphomycosis Due to CARD9 Variants.
https://www.medspoke.co/channel_journal?id=875&tap_id=16139
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Rheumatology (Oxford)
Published October 21, 2026
Validity of the 2023 ACR/EULAR APS classification criteria to pediatric primary APS: inputs from ...
October 23, 2026
Why are you reporting this TALK?
